Synthetic Intelligence & Machine Studying
,
Governance & Threat Administration
,
Healthcare
Additionally: Embedded AI in Pharmaceutical Sector, the Story Behind Apple’s CEO Change
On this week’s panel, 4 ISMG editors look at what’s actually behind Apple’s CEO transition, how pharmaceutical giants are racing to embed synthetic intelligence throughout core operations, and why AI-driven threats are forcing a rethink of how rapidly defenders can reply.
See Additionally: Defending Identification within the Age of AI Assaults
The panelists – Chris Riotta, managing editor, GovInfoSecurity; Marianne Kolbasuk McGee, govt editor, HealthcareInfoSecurity; Michael Novinson, govt editor, ISMG Enterprise; and Jennifer Lawinski, managing editor, CIO.inc – mentioned:
- Apple’s management transition from long-time CEO Tim Cook dinner to John Ternus and why the transfer seems much less like a shakeup and extra like a continuation of Apple’s hardware-first technique – with no obvious plan to deal with AI-based options;
- How Merck’s multiyear take care of Google Cloud displays a broader pharmaceutical sector push to deploy generative and agentic AI throughout analysis, manufacturing and industrial operations, as firms pursue quicker drug improvement whereas grappling with knowledge governance and regulatory danger;
- Why advances in AI are compressing the time between vulnerability discovery and exploitation to close actual time, primarily based on insights from Jeetu Patel, president and chief product officer at Cisco, and what meaning for organizations transferring towards AI-driven safety operations to defend in opposition to machine-speed cyberthreats.
The ISMG Editors’ Panel runs weekly. Do not miss our earlier installments, together with the April 8 version on the implications of Anthropic’s AI bug finder and the April 17 version on the looming onslaught of vulnerabilities found by Claude Mythos.
